Elekta gets FDA OK for monitoring software
Article Thumbnail ImageDecember 17, 2012 -- Radiation oncology firm Elekta has received U.S. Food and Drug Administration 510(k) clearance for its Clarity 4D monitoring software, which monitors motion in the prostate and surrounding tissues and organs during radiation therapy for prostate cancer.

To get access to this article and all of the content on AuntMinnie.com, create a free account or sign-in now.

Member Sign In:
MemberID or E-mail Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  



The software continuously visualizes the prostate's location in real-time and with submillimeter accuracy during the delivery of radiation, according to the company. It is designed to enable hypofractionation techniques that shorten the treatment schedule.